X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (35) 35
female (32) 32
index medicus (31) 31
breast cancer (26) 26
cell line, tumor (25) 25
oncology (21) 21
animals (19) 19
article (19) 19
mice (18) 18
gene expression (15) 15
breast neoplasms - metabolism (14) 14
breast neoplasms - pathology (13) 13
estrogen (13) 13
breast neoplasms - genetics (12) 12
mcf-7 cells (11) 11
cell proliferation - drug effects (10) 10
signal transduction (10) 10
apoptosis (9) 9
cancer (9) 9
medicine (9) 9
metastasis (9) 9
xenograft model antitumor assays (9) 9
development and progression (8) 8
gene expression profiling (8) 8
gene expression regulation, neoplastic (8) 8
gene-expression (8) 8
micrornas - genetics (8) 8
signal transduction - drug effects (8) 8
skin and connective tissue diseases (8) 8
tumorigenesis (8) 8
tumors (8) 8
breast carcinoma (7) 7
cell survival - drug effects (7) 7
estrogen receptor (7) 7
estrogen receptor alpha - metabolism (7) 7
microrna (7) 7
proteins (7) 7
receptors, estrogen - metabolism (7) 7
research article (7) 7
activated protein-kinase (6) 6
cancer cells (6) 6
epithelial-mesenchymal transition (6) 6
estrogen receptor alpha - genetics (6) 6
growth (6) 6
health aspects (6) 6
kinases (6) 6
medical research (6) 6
mice, scid (6) 6
mortality (6) 6
progesterone (6) 6
stem cells (6) 6
activation (5) 5
biochemistry & molecular biology (5) 5
breast (5) 5
breast neoplasms - drug therapy (5) 5
cells (5) 5
epithelial-mesenchymal transition - genetics (5) 5
expression (5) 5
genes (5) 5
genotype & phenotype (5) 5
mice, nude (5) 5
micrornas (5) 5
science (5) 5
studies (5) 5
triple-negative breast cancer (5) 5
alpha (4) 4
antineoplastic agents, hormonal - pharmacology (4) 4
apoptosis - drug effects (4) 4
cancer therapies (4) 4
care and treatment (4) 4
cell cycle (4) 4
cell growth (4) 4
cell movement - genetics (4) 4
chemoresistance (4) 4
drug resistance, neoplasm (4) 4
endocrinology & metabolism (4) 4
estradiol - pharmacology (4) 4
estrogen receptors (4) 4
estrogens (4) 4
glyceollin (4) 4
immunohistochemistry (4) 4
mechanisms (4) 4
mesenchyme (4) 4
metastases (4) 4
micrornas - metabolism (4) 4
mirna (4) 4
multidisciplinary sciences (4) 4
receptors, progesterone - metabolism (4) 4
research (4) 4
reverse transcriptase polymerase chain reaction (4) 4
rna (4) 4
soy (4) 4
surgery (4) 4
triple negative breast neoplasms - genetics (4) 4
adipose tissues (3) 3
antiestrogen resistance (3) 3
antineoplastic agents - pharmacology (3) 3
base sequence (3) 3
biology (3) 3
breast-cancer (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer Research, ISSN 0008-5472, 07/2016, Volume 76, Issue 14 Supplement, pp. 3318 - 3318
Many of the most widely used therapies for the treatment of breast cancer have been associated with enhanced rate of bone loss, including chemotherapies and... 
Journal Article
Molecular Cancer Research, ISSN 1541-7786, 10/2013, Volume 11, Issue 10 Supplement, pp. A016 - A016
Journal Article
Breast Cancer Research, ISSN 1465-5411, 05/2012, Volume 14, Issue 3, pp. R79 - R79
Introduction: Of the more than one million global cases of breast cancer diagnosed each year, approximately fifteen percent are characterized as... 
Panobinostat | Histone deacetylase inhibitor | Xenograft | CDH1 | Epithelial-to-mesenchymal transition | LBH589 | E-cadherin | Triple-negative breast cancer | triple-negative breast cancer | EFFICACY | GENE-EXPRESSION PROFILES | PATTERNS | epithelial-to-mesenchymal transition | EPITHELIAL-MESENCHYMAL TRANSITION | CADHERIN | xenograft | MODELS | ONCOLOGY | histone deacetylase inhibitor | GROWTH | PHASE-I | MOLECULAR-MECHANISMS | Up-Regulation | Receptors, Estrogen - metabolism | Cadherins - metabolism | Apoptosis - drug effects | Humans | Receptor, ErbB-2 - metabolism | Epithelial-Mesenchymal Transition - drug effects | Breast Neoplasms - metabolism | Receptors, Progesterone - metabolism | Cdh1 Proteins | Female | Indoles - pharmacology | Hydroxamic Acids - pharmacology | Cell Survival - drug effects | Gene Expression | Cell Cycle Proteins - metabolism | Random Allocation | Mice, SCID | Breast Neoplasms - drug therapy | Xenograft Model Antitumor Assays | Animals | Cell Cycle | Signal Transduction - drug effects | Breast Neoplasms - pathology | Cell Line, Tumor | Histone Deacetylase Inhibitors - pharmacology | Cell Proliferation - drug effects | Mice | Cell Transformation, Neoplastic - drug effects | Histones - metabolism | Antimitotic agents | Prognosis | Estrogen | Stem cells | Breast cancer | Metastasis | Progesterone | Antineoplastic agents | Enzyme-linked immunosorbent assay | Cell proliferation | Flow cytometry | Histone deacetylase | Animal models | Mesenchyme | Toxicity | Estrogens | Cytology | Confocal microscopy | Malignancy | Signal transduction | CDH1 protein | propidium iodide | Cell cycle | DNA fragmentation | Xenografts | Tumorigenesis | Acetylation | Probes | Age | Cell survival | bromides | biomarkers | ErbB-2 protein | imaging | Tumor suppressor genes | Apoptosis
Journal Article
PLoS ONE, ISSN 1932-6203, 03/2012, Volume 7, Issue 3, p. e32754
Journal Article
Breast Cancer Research, ISSN 1465-5411, 08/2015, Volume 17, Issue 1, p. 112
Introduction: The steady increase in the incidence of obesity among adults has been paralleled with higher levels of obesity-associated breast cancer. While... 
STEM-CELLS | INVASION | ACTIVATION | ONCOLOGY | TISSUE | GROWTH | BODY-MASS INDEX | ALPHA | RISK | DIFFERENTIATION | EPIDEMIOLOGY | RNA, Small Interfering - genetics | Stromal Cells - pathology | Humans | Leptin - metabolism | Epithelial-Mesenchymal Transition - genetics | Stem Cells - metabolism | Breast - metabolism | Obesity - genetics | Cell Movement - genetics | Breast Neoplasms - metabolism | Adipose Tissue - metabolism | MCF-7 Cells | Plasminogen Activator Inhibitor 1 - metabolism | Female | Plasminogen Activator Inhibitor 1 - genetics | Breast - pathology | Gene Expression Regulation, Neoplastic - physiology | Interleukin-6 - metabolism | Gene Expression Regulation, Neoplastic - genetics | Cell Proliferation - genetics | Receptors, Estrogen - genetics | Interleukin-6 - genetics | Matrix Metalloproteinase 2 - metabolism | Stromal Cells - metabolism | Adipose Tissue - pathology | Carcinogenesis - genetics | Coculture Techniques - methods | Mice, SCID | Adipocytes - pathology | Adiposity - genetics | Obesity - metabolism | Obesity - pathology | Carcinogenesis - pathology | Matrix Metalloproteinase 2 - genetics | Neoplasm Metastasis - genetics | Animals | Breast Neoplasms - genetics | Breast Neoplasms - pathology | Neoplasm Metastasis - pathology | Adipocytes - metabolism | Cell Line, Tumor | Stem Cells - pathology | Mice | Adipose tissues | Obesity | Care and treatment | Leptin | Genes | Estrogen | Stem cells | Phenols | Breast cancer | Metastasis | Gene expression | Cancer
Journal Article
Breast Cancer Research, ISSN 1465-5411, 10/2013, Volume 15, Issue 5, pp. R102 - R102
Introduction: Obesity has been associated with increased incidence and mortality of breast cancer. While the precise correlation between obesity and breast... 
INVASION | ADULT WEIGHT CHANGE | ADIPOCYTES | ONCOLOGY | GROWTH | BODY-MASS INDEX | RISK | LEPTIN RECEPTOR | STROMAL CELLS | POSTMENOPAUSAL BREAST-CANCER | EXPRESSION | Receptors, Estrogen - metabolism | Cell Proliferation | Estrogens - pharmacology | Coculture Techniques | Humans | Leptin - metabolism | Aromatase - metabolism | Gene Expression Profiling | Stem Cells - metabolism | Obesity - genetics | Breast Neoplasms - metabolism | Receptors, Progesterone - metabolism | Intercellular Signaling Peptides and Proteins - metabolism | MCF-7 Cells | Estrogen Receptor alpha - metabolism | Female | Membrane Proteins - metabolism | Estrogens - metabolism | Glutathione S-Transferase pi - genetics | Glutathione S-Transferase pi - metabolism | Signal Transduction | Membrane Proteins - genetics | Intercellular Signaling Peptides and Proteins - genetics | Cyclin-Dependent Kinase Inhibitor p16 - genetics | Leptin - genetics | Tumor Burden | Obesity - metabolism | Animals | Breast Neoplasms - genetics | Estrogen Receptor alpha - genetics | Breast Neoplasms - pathology | Cell Transformation, Neoplastic | Adipocytes - metabolism | Cell Line, Tumor | Cyclin-Dependent Kinase Inhibitor p16 - metabolism | Breast Neoplasms - mortality | Mice | Women | Adipose tissues | Obesity | United States | Mortality | Antibodies | Development and progression | Breast cancer | Carcinogenesis | Viral antibodies | Body mass index | Leptin | Progesterone | Health aspects | Biotechnology industry
Journal Article
Breast Cancer Research, ISSN 1465-5411, 03/2012, Volume 14, Issue 2, pp. R45 - R45
Journal Article
Molecular Cancer, ISSN 1476-4598, 11/2010, Volume 9, Issue 1, pp. 295 - 295
Journal Article
Cancer Research, ISSN 0008-5472, 04/2010, Volume 70, Issue 8 Supplement, pp. 4606 - 4606
Journal Article
BMC Cancer, ISSN 1471-2407, 03/2019, Volume 19, Issue 1, pp. 205 - 17
BackgroundTriple-negative breast cancer (TNBC) represents an aggressive subtype with limited therapeutic options. Experimental preclinical models that... 
Mammosphere | Chemoresistance | Patient-derived xenograft | Triple-negative breast cancer | EFFICACY | ONCOLOGY | CELL-CULTURE | INHIBITORS | MESENCHYMAL TRANSITION | DISCOVERY
Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 6/2014, Volume 145, Issue 3, pp. 593 - 604
Triple-negative breast cancer (TNBC) is a highly aggressive breast cancer subtype that lacks effective targeted therapies. The epithelial-to-mesenchymal... 
ZEB2 | ZEB1 | Medicine & Public Health | Epithelial-to-mesenchymal transition | HDAC inhibitor | Oncology | Metastasis | ANTICANCER AGENTS | E-CADHERIN | EPITHELIAL-MESENCHYMAL TRANSITION | ONCOLOGY | GASTRIC-CANCER | COLORECTAL-CANCER | IN-VIVO | GENE-EXPRESSION | HISTONE DEACETYLASE INHIBITORS | PROTEOMIC ANALYSIS | TRANSCRIPTIONAL REPRESSOR | Apoptosis - drug effects | Humans | Epithelial-Mesenchymal Transition - drug effects | Triple Negative Breast Neoplasms - drug therapy | Zinc Finger E-box Binding Homeobox 2 | Repressor Proteins - antagonists & inhibitors | MCF-7 Cells | Neoplasm Metastasis - drug therapy | Neoplasm Invasiveness - pathology | Female | Indoles - pharmacology | Antineoplastic Agents - pharmacology | Breast - pathology | Hydroxamic Acids - pharmacology | Homeodomain Proteins - biosynthesis | Transcription Factors - antagonists & inhibitors | Transcription Factors - biosynthesis | Mice, SCID | Xenograft Model Antitumor Assays | Cell Movement - drug effects | Animals | Repressor Proteins - biosynthesis | Homeodomain Proteins - antagonists & inhibitors | Cell Line, Tumor | Histone Deacetylase Inhibitors - pharmacology | Cell Proliferation - drug effects | Mice | Zinc Finger E-box-Binding Homeobox 1 | Breast cancer | Gene expression | Health aspects | Stem cells | metastasis | epithelial-to-mesenchymal transition
Journal Article
PLoS ONE, ISSN 1932-6203, 11/2012, Volume 7, Issue 11, p. e49067
In breast carcinomas, increased levels of insulin-like growth factor 1 (IGF-1) can act as a mitogen to augment tumorigenesis through the regulation of MAPK and... 
PATHWAYS | TARGETING BCL2 | METASTASIS | CARCINOMA CELLS | GASTRIC-CANCER | MULTIDISCIPLINARY SCIENCES | RESISTANCE | SUPPRESSES | LET-7 | MECHANISMS | MICRORNA | Insulin-Like Growth Factor I - pharmacology | Mitogen-Activated Protein Kinase Kinases - genetics | Oligonucleotide Array Sequence Analysis | Humans | MicroRNAs - metabolism | Gene Expression Profiling | Insulin-Like Growth Factor I - genetics | Proto-Oncogene Proteins c-akt - genetics | Breast Neoplasms - metabolism | Mitogen-Activated Protein Kinase Kinases - metabolism | Female | Gene Expression Regulation, Neoplastic - drug effects | Carcinoma - pathology | Proto-Oncogene Proteins c-akt - metabolism | Real-Time Polymerase Chain Reaction | Cell Survival - drug effects | Mitogen-Activated Protein Kinase Kinases - antagonists & inhibitors | Breast Neoplasms - genetics | Signal Transduction - drug effects | Breast Neoplasms - pathology | Cell Line, Tumor | Carcinoma - genetics | Cell Proliferation - drug effects | MicroRNAs - genetics | Protein Kinase Inhibitors - pharmacology | Carcinoma - metabolism | Insulin-Like Growth Factor I - metabolism | Proto-Oncogene Proteins c-akt - antagonists & inhibitors | Breast cancer | MicroRNA | Insulin-like growth factor I | Estrogens | Oncology | AKT protein | Biology | Insulin-like growth factors | Metastasis | Kinases | Stomach cancer | Proteins | Liver cancer | Breast carcinoma | Signal transduction | Cell growth | Pathways | Cell cycle | Tumorigenesis | Medical research | Cell survival | Hematology | MiRNA | MAP kinase | Gene expression | Insulin | Medicine | Signaling | MicroRNAs | Breast | Tumor suppressor genes | Cancer | Apoptosis
Journal Article
Journal of Health Care for the Poor and Underserved, ISSN 1049-2089, 02/2013, Volume 24, Issue suppl 1, pp. 104 - 111
Triple negative breast cancer (TNBC) is subtype of breast disease devoid of the estrogen, progesterone, and Her2/neu receptors which are targets for... 
Journal Article
Journal of Health Care for the Poor and Underserved, ISSN 1049-2089, 02/2013, Volume 24, Issue suppl 1, pp. 36 - 46
There is growing interest in the diverse signaling pathways that regulate and affect breast tumorigenesis, including the role of phytochemicals and the... 
Journal Article
Journal of Health Care for the Poor and Underserved, ISSN 1049-2089, 02/2013, Volume 24, Issue suppl 1, pp. 36 - 46
There is growing interest in the diverse signaling pathways that regulate and affect breast tumorigenesis, including the role of phytochemicals and the... 
Journal Article